InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Moderna

MRNA Clue Score25
United States Fiscal year ends December CIK 0001682852
$225.00 +14.21% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $225.00 −26.25% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 7 Dec 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.11Operating income−0.22Net income−0.22Fiscal year 2017Revenue0.21 +89.9%Operating income−0.27Net income−0.26Fiscal year 2018Revenue0.14 −34.4%Operating income−0.41Net income−0.38Fiscal year 2019Revenue0.06 −55.4%Operating income−0.55Net income−0.51EPS, diluted−1.55Fiscal year 2020Revenue0.80 +1,233.7%Operating income−0.76Net income−0.75EPS, diluted−1.96Fiscal year 2021Revenue18.47 +2,200.2%Operating income13.30Net income12.20EPS, diluted28.29Fiscal year 2022Revenue19.26 +4.3%Operating income9.42Net income8.36 −31.5%EPS, diluted20.12 −28.9%Fiscal year 2023Revenue6.85 −64.4%Operating income−4.24Net income−4.71 −156.4%EPS, diluted−12.33 −161.3%Fiscal year 2024Revenue3.24 −52.7%Operating income−3.95Net income−3.56EPS, diluted−9.28Fiscal year 2025Revenue1.94 −39.9%Operating income−3.07Net income−2.82EPS, diluted−7.26
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.11 0.21 0.14 0.06 0.80 18.47 19.26 6.85 3.24 1.94
Growth +89.9% −34.4% −55.4% +1,233.7% +2,200.2% +4.3% −64.4% −52.7% −39.9%
Operating income −0.22 −0.27 −0.41 −0.55 −0.76 13.30 9.42 −4.24 −3.95 −3.07
Net income −0.22 −0.26 −0.38 −0.51 −0.75 12.20 8.36 −4.71 −3.56 −2.82
Growth −31.5% −156.4%
EPS, diluted n/a n/a n/a −1.55 −1.96 28.29 20.12 −12.33 −9.28 −7.26
Growth −28.9% −161.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−206.4%Net margin−199.5%Free cash flow margin31.0%Fiscal year 2017Operating margin−130.9%Net margin−124.3%Free cash flow margin−189.4%Fiscal year 2018Operating margin−306.0%Net margin−284.8%Free cash flow margin−323.3%Fiscal year 2019Operating margin−906.8%Net margin−853.7%Free cash flow margin−815.5%Fiscal year 2020Operating margin−95.0%Net margin−93.0%Free cash flow margin244.0%Fiscal year 2021Operating margin72.0%Net margin66.1%Free cash flow margin72.2%Fiscal year 2022Operating margin48.9%Net margin43.4%Free cash flow margin23.8%Fiscal year 2023Operating margin−61.9%Net margin−68.8%Free cash flow margin−55.9%Fiscal year 2024Operating margin−121.9%Net margin−110.0%Free cash flow margin−125.3%Fiscal year 2025Operating margin−158.1%Net margin−145.2%Free cash flow margin−106.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −206.4% −130.9% −306.0% −906.8% −95.0% 72.0% 48.9% −61.9% −121.9% −158.1%
Net margin −199.5% −124.3% −284.8% −853.7% −93.0% 66.1% 43.4% −68.8% −110.0% −145.2%
Free cash flow margin 31.0% −189.4% −323.3% −815.5% 244.0% 72.2% 23.8% −55.9% −125.3% −106.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.07Capital expenditure−0.03Free cash flow0.03Fiscal year 2017Operating cash flow−0.33Capital expenditure−0.06Free cash flow−0.39 −1,260.7%Fiscal year 2018Operating cash flow−0.33Capital expenditure−0.11Free cash flow−0.44Fiscal year 2019Operating cash flow−0.46Capital expenditure−0.03Free cash flow−0.49Buybacks0.00Fiscal year 2020Operating cash flow2.03Capital expenditure−0.07Free cash flow1.96Buybacks0.00Fiscal year 2021Operating cash flow13.62Capital expenditure−0.28Free cash flow13.34 +580.8%Buybacks−0.86Fiscal year 2022Operating cash flow4.98Capital expenditure−0.40Free cash flow4.58 −65.6%Buybacks−3.33Fiscal year 2023Operating cash flow−3.12Capital expenditure−0.71Free cash flow−3.83 −183.5%Buybacks−1.15Fiscal year 2024Operating cash flow−3.00Capital expenditure−1.05Free cash flow−4.06Buybacks0.00Fiscal year 2025Operating cash flow−1.87Capital expenditure−0.19Free cash flow−2.07Buybacks−0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.07 −0.33 −0.33 −0.46 2.03 13.62 4.98 −3.12 −3.00 −1.87
Capital expenditure −0.03 −0.06 −0.11 −0.03 −0.07 −0.28 −0.40 −0.71 −1.05 −0.19
Free cash flow 0.03 −0.39 −0.44 −0.49 1.96 13.34 4.58 −3.83 −4.06 −2.07
Growth −1,260.7% +580.8% −65.6% −183.5%
Buybacks n/a n/a n/a 0.00 0.00 −0.86 −3.33 −1.15 0.00 −0.00

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.05Shareholders’ equity−0.33Fiscal year 2017Cash0.13Shareholders’ equity−0.55Fiscal year 2018Cash0.66Shareholders’ equity1.53Fiscal year 2019Cash0.24Shareholders’ equity1.18Fiscal year 2020Cash2.62Shareholders’ equity2.56Fiscal year 2021Cash6.85Shareholders’ equity14.15Fiscal year 2022Cash3.21Shareholders’ equity19.12Fiscal year 2023Cash2.91Shareholders’ equity13.85Fiscal year 2024Cash1.93Total debt0.00Net cash (debt)1.93Shareholders’ equity10.90Debt to equity0.00Fiscal year 2025Cash2.60Total debt0.59Net cash (debt)2.01Shareholders’ equity8.65Debt to equity0.07
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.05 0.13 0.66 0.24 2.62 6.85 3.21 2.91 1.93 2.60
Total debt n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.59
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a n/a 1.93 2.01
Shareholders’ equity −0.33 −0.55 1.53 1.18 2.56 14.15 19.12 13.85 10.90 8.65
Debt to equity n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.07

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−206.4% −130.9% −306.0% −906.8% −95.0% 72.0% 48.9% −61.9% −121.9% −158.1%
−198.5% −124.4% −284.6% −855.4% −92.7% 71.9% 49.7% −57.6% −111.5% −142.4%
−199.5% −124.3% −284.8% −853.7% −93.0% 66.1% 43.4% −68.8% −110.0% −145.2%
31.0% −189.4% −323.3% −815.5% 244.0% 72.2% 23.8% −55.9% −125.3% −106.2%
Spending
253.4% 199.4% 336.2% 823.8% 170.6% 10.8% 17.1% 70.8% 140.4% 161.1%
53.0% 31.4% 69.8% 182.7% 23.4% 3.1% 5.9% 22.6% 36.3% 52.4%
30.6% 28.4% 78.3% 53.1% 8.5% 1.5% 2.1% 10.3% 32.5% 9.9%
n/a n/a n/a n/a n/a 8.2% 12.7% n/a n/a n/a
Returns
n/a n/a −25.1% −43.7% −29.2% 86.3% 43.7% −34.0% −32.7% −32.6%
n/a −23.6% −19.6% −32.3% −10.2% 49.5% 32.3% −25.6% −25.2% −22.9%
Balance and payout
n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.07
n/a 42.3% 22.0% 26.1% 65.1% 42.7% 26.0% 24.8% 22.9% 29.9%
n/a n/a n/a n/a 0.0% 6.4% 72.7% n/a n/a n/a